Protagonist Therapeutics Inc (PTGX)

Receivables turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue (ttm)	US$ in thousands	315,090	60,137	123	123	982	26,704	35,221	45,507	46,913	27,380	24,330	27,139	31,091	28,549	25,678	12,604	6,408	4,321	3,955	10,051
Receivables	US$ in thousands	—	—	—	50	51	3,852	620	3,363	28,504	5,333	4,509	9,855	5,819	3,821	3,324	3,273	3,747	7,499	2,118	6,310
Receivables turnover		—	—	—	2.46	19.25	6.93	56.81	13.53	1.65	5.13	5.40	2.75	5.34	7.47	7.73	3.85	1.71	0.58	1.87	1.59

March 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $315,090K ÷ $—K
= —

The receivables turnover ratio for Protagonist Therapeutics Inc has shown fluctuation over the past quarters, ranging from as low as 0.58 to as high as 56.81. A higher receivables turnover ratio indicates that the company is efficiently collecting its accounts receivable and converting them into cash.

In the latest quarter, the receivables turnover ratio was 2.46, which suggests that the company took approximately 2.46 times to collect its accounts receivable during the period. This figure is lower compared to the previous quarter's ratio of 19.25, indicating a decrease in the efficiency of the company in collecting receivables.

It is essential for Protagonist Therapeutics Inc to monitor its receivables turnover ratio consistently and aim to improve it over time to ensure timely collection of outstanding payments from customers and maintain healthy cash flow.